Alfresa Holdings (2784) · FactFirst stated
FY2022-Q1 Research and Development Expenses of ¥355 million
First written in FY2022-Q1. . Latest entry: FY2022-Q1.
1entries
1years
0from disclosures
How it moved
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 205 companies write about · 0 as a headwind · 194 as a tailwind
0 other companies' latest entry also says "First stated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 209 threads.Full recordFilings, disclosures and news, newest first